Gene · 3131
Papers1,870
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,870
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional characterization of ABCA4 genetic variants related to Stargardt disease. | Sci Rep | 2022 | 36566289 | PubTator, text mining | PubMed |
| DNA Methylation Analysis Reveals Distinct Patterns in Satellite Cell-Derived Myogenic Progenitor Cells of Subjects with Spastic Cerebral Palsy. | J Pers Med | 2022 | 36556199 | PubTator, text mining | PubMed |
| Primary Breast Angiosarcoma: Comparative Transcriptome Analysis. | Int J Mol Sci | 2022 | 36555675 | PubTator, text mining | PubMed |
| Peripheral Bone Relapse of Paediatric TCF3-HLF Positive Acute Lymphoblastic Leukaemia during Haematopoietic Stem Cell Transplantation: A Case Report. | Children (Basel) | 2022 | 36553362 | PubTator, text mining | PubMed |
| Circadian Genes Expression Patterns in Disorders Due to Enzyme Deficiencies in the Heme Biosynthetic Pathway. | Biomedicines | 2022 | 36551954 | PubTator, text mining | PubMed |
| Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma. | Biomedicines | 2022 | 36551790 | PubTator, text mining | PubMed |
| Lehnertz B, Chagraoui J, MacRae T, et al. HLF expression defines the human hematopoietic stem cell state. Blood. 2021;138(25):2642-2654. | Blood | 2022 | 36548013 | PubTator, text mining | PubMed |
| Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods. | Sci Rep | 2022 | 36543921 | PubTator, text mining | PubMed |
| Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer. | Front Cell Dev Biol | 2022 | 36531950 | PubTator, text mining | PubMed |
| Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma. | Pathol Oncol Res | 2022 | 36507118 | PubTator, text mining | PubMed |
| Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery. | Cancers (Basel) | 2022 | 36497286 | PubTator, text mining | PubMed |
| Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality. | Cancers (Basel) | 2022 | 36497275 | PubTator, text mining | PubMed |
| Enzyme-Linked Aptamer Kits for Rapid, Visual, and Sensitive Determination of Lactoferrin in Dairy Products. | Foods | 2022 | 36496570 | PubTator, text mining | PubMed |
| Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches. | Onco Targets Ther | 2022 | 36474506 | PubTator, text mining | PubMed |
| Role of the Meso Substituent in Defining the Reduction of Uranyl Dipyrrin Complexes. | Inorg Chem | 2022 | 36472325 | PubTator, text mining | PubMed |
| Targeting ferroptosis, the achilles' heel of breast cancer: A review. | Front Pharmacol | 2022 | 36467032 | PubTator, text mining | PubMed |
| Review targeted drug delivery systems for norcantharidin in cancer therapy. | J Nanobiotechnology | 2022 | 36463199 | PubTator, text mining | PubMed |
| Comprehensive comparison of gene expression diversity among a variety of human stem cells. | NAR Genom Bioinform | 2022 | 36458020 | PubTator, text mining | PubMed |
| Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia. | Proc Natl Acad Sci U S A | 2022 | 36442087 | PubTator, text mining | PubMed |
| Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin. | Molecules | 2022 | 36431851 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3131/papers?page=16